PCOS Symptoms in Teenagers: What's Normal Puberty and What Isn't

What counts as a PCOS symptom in a teenager, and what counts as normal puberty?

Two features count toward a PCOS diagnosis in a teenager — persistent irregular cycles and excess androgens together — while a third feature used in adults, polycystic-looking ovaries on ultrasound, is not used at all at this age. That is a narrower test than the adult version, built because so much of what looks like PCOS in the teenage years is puberty behaving normally: cycles are commonly irregular while the hormonal feedback loop that regulates ovulation is still maturing, mild acne affects most teenagers at some point, and ovaries that would flag as polycystic on a scan are common in adolescents who have no hormonal problem at all.

A 2024 systematic review and meta-analysis pooling 20 studies of 14,010 adolescents put a number on how much difference the narrower test makes: global PCOS prevalence came out at 9.8% under an approach that still counts ovarian ultrasound findings, versus 6.3% under the current international guideline criteria that leave ultrasound out. That is not a rounding difference — it is roughly a third of adolescent PCOS “cases” disappearing once the tighter, teen-specific bar is applied.

Why is the bar deliberately higher for a teenager than for an adult?

The 2023 international guideline requires both irregular cycles and excess androgens together in adolescents, where an adult needs only two of three possible features — a stricter combination built specifically to stop normal puberty from being mislabeled as lifelong disease. Ultrasound findings are dropped from the adolescent test entirely: the guideline states plainly that “there are no definitive criteria to define polycystic ovary morphology on ultrasound in adolescents; hence, it is not recommended in adolescents,” and separately that anti-Müllerian hormone (AMH), now an accepted stand-in for ultrasound in adults, “should not yet be used in adolescents” either.

The reasoning is developmental, not administrative. In most adolescents, androgen levels do not settle into adult reference ranges until 12 to 15 years of age, so a single androgen reading taken earlier is harder to interpret against adult cut-offs. Adolescent ovaries are also naturally larger and more multi-follicular than adult ovaries as a normal feature of reproductive maturation — the same appearance that would flag “polycystic” on a scan in an adult is close to typical in a healthy teenager, which is exactly why no validated ultrasound threshold exists for this age group.

What is the “increased risk” category, and how common is it really?

Nearly half of one adolescent cohort — 46% of 421 obese girls, in a 2025 Turkish study — met the guideline’s “at risk” category rather than a full PCOS diagnosis, while only 8.3% met every criterion required for diagnosis itself. That gap is larger than most people expect between having some features of PCOS and meeting all of them, and it is exactly the population the guideline built a middle category to hold rather than force into a premature yes-or-no label.

The guideline’s own term is “increased risk,” and it applies to adolescents who have some PCOS features without yet meeting full diagnostic criteria. Three specific patterns are named as reasons to place someone in this category and plan a re-check: features present before starting a combined contraceptive pill, features that persist rather than settle over time, and significant weight gain during adolescence — tracked as a marker the criteria watch for, not something the guideline treats as a personal failing. Reassessment is advised at or before full reproductive maturity, defined as 8 years after a first period.

Why does over-diagnosis in a teenager actually matter?

A PCOS label given at 15 carries lifelong weight, and the researchers behind the adolescent criteria said so directly: in a 2020 commentary, the guideline’s own lead authors wrote that inconsistent diagnosis in either direction — over- or under-diagnosis — “exasperates affected women and limits timely opportunities for intervention to minimize associated comorbidities.” That is not a hypothetical concern. The same tightened criteria that produced the 9.8%-to-6.3% shift above, in a 2020 study of 227 adolescents in Australia’s Raine cohort, cut individual diagnoses nearly in half: 66 girls (29.1%) were classed as having PCOS under the older approach, versus 37 (16.3%) under the updated criteria applied to the exact same 227 participants. Roughly half of the adolescents who would have been told they had PCOS a decade ago would not meet the current bar.

The 2023 guideline requires screening for depression and requires screening for anxiety in every adolescent assessed for PCOS — not as an optional add-on, but as its own numbered recommendation, alongside a separate instruction that clinicians discuss the timing of assessment with a patient and her parent or guardian “considering diagnostic challenges at this life stage and psychosocial and cultural factors.” Building that discussion and that screening requirement directly into the diagnostic pathway is itself evidence of how seriously the people who wrote these criteria take the psychological weight of the label they are describing.

When does a teenager actually need testing now, rather than waiting?

Severe or persistent acne, hirsutism scored as clinically significant, no period at all by age 15, or irregular cycles occurring together with clear androgen signs all warrant assessment now rather than a wait-and-see approach — over-diagnosis concerns are a reason to hold off on a single irregular cycle in the first year after menarche, not a reason to defer a genuinely concerning pattern. The guideline’s full breakdown of exactly which cycle lengths count as irregular at each point after a first period, and which combinations warrant testing immediately versus tracking over time, is covered in more depth in the adolescent PCOS diagnostic criteria explained in full.

Two symptoms deserve their own look regardless of where a teenager falls on the wait-or-test question: what actually counts as PCOS-pattern acne and how hirsutism is scored on a validated scale, rather than judged by eye. Both are more specific, and more useful to bring to an appointment, than “I think I have excess hair” or “my skin is bad.”

Who this does not settle

Being placed in the “increased risk” category is not a diagnosis, and it is not destiny — the category exists precisely because some adolescents who meet only one soft criterion will not go on to meet full criteria once puberty finishes. A label given at 15 is not guaranteed to be the same finding at 25, which is exactly why the guideline built a reassessment step into the middle category instead of forcing a permanent yes-or-no answer at the first appointment. None of the numbers above argue that a genuinely concerning pattern — severe acne, scored hirsutism, absent periods, or androgen signs alongside irregular cycles — should be waited out. They argue against turning normal puberty into a diagnosis, not against taking a real one seriously. The emotional weight of a PCOS diagnosis at any age is worth naming honestly with a teenager, rather than assumed away in either direction.

One naming note: in May 2026, PCOS was renamed polyendocrine metabolic ovarian syndrome, or PMOS, by a global consensus of more than 50 organisations. None of the adolescent criteria above changed — only the label did. This article uses PCOS because that is still what most people search.

Your next step

Before an appointment, write down the date of your first period, the length of your last several cycles if you can reconstruct them, and whether acne or hair growth started gradually or suddenly. Almost every threshold above is defined by time — years since menarche, whether a feature has persisted or resolved — rather than by a single reading, so a dated timeline is what turns “my periods are irregular” into something a clinician can actually assess against the guideline. The wider PCOS symptoms section covers what else is worth tracking alongside cycles and skin.